Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,431 | -10,929 | -5,234 | -29,931 | -22,359 |
| Depreciation Amortization | 850 | 583 | 285 | 1,004 | 718 |
| Accounts receivable | 115 | -219 | -127 | -202 | -311 |
| Accounts payable and accrued liabilities | -234 | -189 | -468 | 505 | 607 |
| Other Working Capital | 255 | -397 | -237 | 41 | -511 |
| Other Operating Activity | -1,756 | -396 | -51 | 4,717 | 4,486 |
| Operating Cash Flow | $-19,201 | $-11,546 | $-5,832 | $-23,867 | $-17,369 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -509 | -356 | -168 | -756 | -564 |
| Net Acquisitions | 109 | 7,014 | 7,014 | N/A | 5,136 |
| Investing Cash Flow | $-400 | $6,658 | $6,846 | $-756 | $4,573 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 5,136 | N/A |
| Common Stock Issued | 9,304 | 290 | 290 | 15,587 | 15,570 |
| Financing Cash Flow | $9,304 | $290 | $290 | $20,723 | $15,570 |
| Beginning Cash Position | 24,120 | 24,120 | 24,120 | 28,020 | 28,020 |
| End Cash Position | 13,824 | 19,522 | 25,424 | 24,120 | 30,794 |
| Net Cash Flow | $-10,297 | $-4,598 | $1,304 | $-3,900 | $2,774 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,201 | -11,546 | -5,832 | -23,867 | -17,369 |
| Capital Expenditure | -509 | -356 | -168 | -756 | -564 |
| Free Cash Flow | -19,710 | -11,902 | -6,000 | -24,624 | -17,933 |